A diverse coalition of groups, including NCPA, sent letters on Feb. 5 to congressional leadership and the president emphasizing the importance of achieving PBM reform in this spring’s government funding legislation. The other co-signatories to the letter are America’s Agenda, Blue Shield of California, the ERISA Industry Committee, National Association of Chain Drug Stores, PBM Accountability Project, and Transparency-Rx.
NCPA
